<DOC>
	<DOCNO>NCT02421978</DOCNO>
	<brief_summary>The purpose study try provide data link impact increase inflammatory cytokine result chemotherapy relationship increase level CNS glutamate related behavioral cognitive consequence breast cancer patient . The investigator use neuropsychiatric assessment , blood sample Magnetic Resonance Spectroscopy ( MRS ) collect study data .</brief_summary>
	<brief_title>Inflammation-Induced CNS Glutamate During Breast Cancer Treatment</brief_title>
	<detailed_description>Approximately 70 % woman breast cancer experience behavioral and/or cognitive symptom treatment chemotherapy approximately 30 % woman continue experience symptom month year treatment completion . There mount data suggest inflammation may involve indicate chemotherapy-treated breast cancer patient exhibit high inflammatory marker non-chemotherapy-treated patient , inflammatory marker include interleukin ( IL ) -6 soluble tumor necrosis factor ( sTNFR2 ) associate chemotherapy-induced depression fatigue .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Female breast cancer patient undergone surgery ( lumpectomy mastectomy ) without neoadjuvant adjuvant chemotherapy Age 2165 year Taking trastuzumab</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cognitive dysfunction</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Decreased motivation</keyword>
</DOC>